WOLVERINE ASSET MANAGEMENT LLC
Position in ESLA — Estrella Immunopharma, Inc.
CIK 1279891
CHICAGO, IL
Position in ESLA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$496
+$496 QoQ
Shares Held
468
-78.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WOLVERINE ASSET MANAGEMENT LLC holds $2,231,368 across 19 Biotechnology names. ESLA ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
22,815 | $1,713,178 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,322 | $249,924 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
4,920 | $107,059 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,521 | $72,353 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
2,127 | $42,625 | |
| 6 | YDES |
YD Bio Ltd
|
4,886 | $37,622 | |
| 7 | CYTK |
Cytokinetics Inc
|
120 | $7,909 | |
| 8 | ESLA |
Estrella Immunopharma, Inc.
This page
|
468 | $496 |
All Filings in ESLA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $496 | 468 | Shares | Defined | 2026-05-04 | |
| 2025-09-30 ESLAW | — | 2,191 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 ESLAW | — | 2,191 | Shares | Defined | 2025-08-04 | |
| 2024-12-31 ESLAW | — | 3,256 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 ESLAW | — | 4,303 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 ESLAW | — | 5,703 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 ESLAW | — | 5,703 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 ESLAW | — | 5,703 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||